• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者睑板腺的变化

Changes of meibomian glands in patients with type 2 diabetes mellitus.

作者信息

Yu Tao, Shi Wei-Yun, Song Ai-Ping, Gao Yang, Dang Guang-Fu, Ding Gang

机构信息

Qingdao University, Qingdao 266071, Shandong Province, China; Shandong Provincial Qianfoshan Hospital, Jinan 250014, Shandong Province, China.

Shandong Eye Hospital, Shandong Eye Institute, Jinan 250021, Shandong Province, China.

出版信息

Int J Ophthalmol. 2016 Dec 18;9(12):1740-1744. doi: 10.18240/ijo.2016.12.06. eCollection 2016.

DOI:10.18240/ijo.2016.12.06
PMID:28003972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5154985/
Abstract

AIM

To investigate the morphological changes of meibomian glands in patients with type 2 diabetes mellitus (DM).

METHODS

Of 118 eyes (118 patients) with type 2 DM (DM group) and 100 eyes of 100 control subjects (control group) were enrolled. After completing an ocular surface disease index (OSDI) questionnaire, the non-invasive tear film break-up time (NI-BUT) and the structure of the meibomian glands (MGs, meibography) were assessed by the Keratograph 5M system. Partial or complete loss of MG was scored for each eyelid from grade 0 (no loss) to grade 3 (lost area was >2/3 of the total MG area), which were also examined by laser scanning confocal microscopy (LSCM). The primary outcomes were meibomian gland acinar unit density (MGAUD), meibomian gland acinar longest diameter (MGALD) and meibomian gland acinar shortest diameter (MGASD).

RESULTS

Compared with control group, the OSDI was significantly higher in DM group (=-5.916; <0.001), while the NI-BUT was significantly lower (=-7.765; <0.001). Keratograph showed that there were more MGs dropout in DM group than that in control group. The meiboscore was significantly higher in DM group compared with control group (=-3.937; <0.001). LSCM revealed that there were cytological alterations of MGs in DM group compared with control group, which included enlargement of MG acinar units and decreased in density of MG acinar units. Specifically, there were lower MGAUD, larger MGALD and MGASD in DM group than control group (=-10.120, -9.4442, -7.771; <0.001).

CONCLUSION

Compared with the normal control participants, the patients with type 2 DM had more unstable tear films and severe symptoms of dry eye. Using Keratograph 5M system and LSCM, we found that the patients with type 2 DM had more significant morphological and cytological changes and dysfunction in MGs.

摘要

目的

研究2型糖尿病(DM)患者睑板腺的形态学变化。

方法

纳入118例2型糖尿病患者的118只眼(DM组)和100例对照者的100只眼(对照组)。完成眼表疾病指数(OSDI)问卷后,使用角膜地形图仪5M系统评估无创泪膜破裂时间(NI-BUT)和睑板腺(MGs,睑板腺造影)结构。对每个眼睑的MG部分或完全缺失进行评分,从0级(无缺失)到3级(缺失面积>MG总面积的2/3),同时通过激光扫描共聚焦显微镜(LSCM)进行检查。主要观察指标为睑板腺腺泡单位密度(MGAUD)、睑板腺腺泡最长直径(MGALD)和睑板腺腺泡最短直径(MGASD)。

结果

与对照组相比,DM组的OSDI显著更高(=-5.916;<0.001),而NI-BUT显著更低(=-7.765;<0.001)。角膜地形图显示,DM组的MG缺失比对照组更多。DM组的睑板腺评分显著高于对照组(=-3.937;<0.001)。LSCM显示,与对照组相比,DM组的MG存在细胞学改变,包括MG腺泡单位增大和MG腺泡单位密度降低。具体而言,DM组的MGAUD低于对照组,MGALD和MGASD大于对照组(=-10.120,-9.4442,-7.771;<0.001)。

结论

与正常对照者相比,2型糖尿病患者的泪膜更不稳定,干眼症状更严重。使用角膜地形图仪5M系统和LSCM,我们发现2型糖尿病患者的MG存在更显著的形态学和细胞学变化及功能障碍。

相似文献

1
Changes of meibomian glands in patients with type 2 diabetes mellitus.2型糖尿病患者睑板腺的变化
Int J Ophthalmol. 2016 Dec 18;9(12):1740-1744. doi: 10.18240/ijo.2016.12.06. eCollection 2016.
2
Morphological and cytological changes of meibomian glands in patients with type 2 diabetes mellitus.2型糖尿病患者睑板腺的形态学和细胞学变化
Int J Ophthalmol. 2019 Sep 18;12(9):1415-1419. doi: 10.18240/ijo.2019.09.07. eCollection 2019.
3
[In vivo confocal microscopy evaluation of meibomian glands in meibomian gland dysfunction patients].睑板腺功能障碍患者睑板腺的体内共聚焦显微镜评估
Zhonghua Yan Ke Za Zhi. 2016 Sep 11;52(9):649-56. doi: 10.3760/cma.j.issn.0412-4081.2016.09.004.
4
Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy.使用体内激光共聚焦显微镜对慢性移植物抗宿主病中睑板腺的形态学评估。
Mol Vis. 2011;17:2533-43. Epub 2011 Sep 29.
5
The efficacy, sensitivity, and specificity of in vivo laser confocal microscopy in the diagnosis of meibomian gland dysfunction.体内激光共聚焦显微镜在诊断睑板腺功能障碍中的疗效、敏感性和特异性。
Ophthalmology. 2010 Apr;117(4):665-72. doi: 10.1016/j.ophtha.2009.12.029. Epub 2010 Mar 1.
6
Confocal Microscopy Evaluation of Meibomian Gland Dysfunction in Dry Eye Patients with Different Symptoms.不同症状干眼患者睑板腺功能障碍的共聚焦显微镜评估
Chin Med J (Engl). 2016 Nov 5;129(21):2617-2622. doi: 10.4103/0366-6999.192782.
7
Meibomian Gland Alteration in Patients with Primary Chronic Dacryocystitis: An In vivo Confocal Microscopy Study.原发性慢性泪囊炎患者睑板腺改变:一项活体共聚焦显微镜研究
Curr Eye Res. 2015;40(8):772-9. doi: 10.3109/02713683.2014.959608. Epub 2014 Sep 30.
8
In vivo confocal microscopy of meibomian glands in primary blepharospasm: A prospective case-control study in a Chinese population.原发性睑痉挛患者睑板腺的体内共聚焦显微镜检查:一项中国人群的前瞻性病例对照研究。
Medicine (Baltimore). 2016 Jun;95(23):e3833. doi: 10.1097/MD.0000000000003833.
9
The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction.体内激光共聚焦显微镜在睑板腺功能障碍诊断和评估中的应用。
Mol Vis. 2008 Jul 9;14:1263-71.
10
In vivo confocal microscopy of meibomian glands in glaucoma.青光眼患者的睑板腺的共焦显微镜检查。
Br J Ophthalmol. 2013 Mar;97(3):343-9. doi: 10.1136/bjophthalmol-2012-302597. Epub 2012 Dec 25.

引用本文的文献

1
Meibomian gland atrophy in children with allergic conjunctivitis.过敏性结膜炎患儿的睑板腺萎缩
Int J Ophthalmol. 2025 May 18;18(5):832-839. doi: 10.18240/ijo.2025.05.07. eCollection 2025.
2
Association of peripheral neuropathy with dry eye disease and meibomian gland dysfunction in patients with type 1 diabetes.1型糖尿病患者周围神经病变与干眼症和睑板腺功能障碍的关联。
Int Ophthalmol. 2025 Feb 7;45(1):61. doi: 10.1007/s10792-025-03420-w.
3
Meibomian Gland Dysfunction and Dropout in Diabetic Patients with Non-Proliferative Diabetic Retinopathy.非增殖性糖尿病视网膜病变糖尿病患者的睑板腺功能障碍与脱落
Bioengineering (Basel). 2024 Sep 10;11(9):907. doi: 10.3390/bioengineering11090907.
4
Improvement in signs and symptoms of severe dry eye disease after dual therapy with high-potency steroids and 0.05% cyclosporine.强效能类固醇与 0.05%环孢素联合治疗重度干眼综合征后症状和体征的改善。
Ann Med. 2024 Dec;56(1):2391019. doi: 10.1080/07853890.2024.2391019. Epub 2024 Aug 19.
5
Inflammation mechanism and anti-inflammatory therapy of dry eye.干眼的炎症机制与抗炎治疗
Front Med (Lausanne). 2024 Feb 14;11:1307682. doi: 10.3389/fmed.2024.1307682. eCollection 2024.
6
Non-contact meibography changes according to disease activity in rheumatoid arthritis cases.非接触式睑板腺成像变化与类风湿关节炎病例的疾病活动度有关。
BMC Ophthalmol. 2023 Nov 13;23(1):454. doi: 10.1186/s12886-023-03194-8.
7
Identifying Meibomian Gland Dysfunction Biomarkers in a Cohort of Patients Affected by DM Type II.在一组II型糖尿病患者中识别睑板腺功能障碍生物标志物。
Vision (Basel). 2023 Mar 24;7(2):28. doi: 10.3390/vision7020028.
8
Study of dry eye disease in type 2 diabetes mellitus and its association with diabetic retinopathy in Western India.在印度西部研究 2 型糖尿病中的干眼症及其与糖尿病视网膜病变的关系。
Indian J Ophthalmol. 2023 Apr;71(4):1463-1467. doi: 10.4103/IJO.IJO_2770_22.
9
Mechanistic investigations of diabetic ocular surface diseases.糖尿病性眼表疾病的发病机制研究。
Front Endocrinol (Lausanne). 2022 Dec 16;13:1079541. doi: 10.3389/fendo.2022.1079541. eCollection 2022.
10
Meibomian gland morphological changes in ocular herpes zoster patients based on AI analysis.基于人工智能分析的眼部带状疱疹患者睑板腺形态变化
Front Cell Dev Biol. 2022 Dec 1;10:1094044. doi: 10.3389/fcell.2022.1094044. eCollection 2022.

本文引用的文献

1
Noninvasive Imaging of Tear Film Dynamics in Eyes With Ocular Surface Disease.眼表疾病患者泪膜动力学的无创成像
Cornea. 2015 Oct;34 Suppl 10:S48-52. doi: 10.1097/ICO.0000000000000570.
2
Dry eye disease in type 2 diabetes mellitus; comparison of the tear osmolarity test with other common diagnostic tests: a diagnostic accuracy study using STARD standard.2型糖尿病中的干眼疾病;泪液渗透压测试与其他常见诊断测试的比较:一项采用STARD标准的诊断准确性研究
J Diabetes Metab Disord. 2015 Apr 29;14:39. doi: 10.1186/s40200-015-0157-y. eCollection 2015.
3
Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea.酒渣鼻患者干眼和睑板腺功能障碍的睑板腺造影评估
Cornea. 2015 May;34(5):497-9. doi: 10.1097/ICO.0000000000000393.
4
Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.原发性干燥综合征患者与非干眼对照者睑板腺的红外成像和脂质层评估。
Invest Ophthalmol Vis Sci. 2015 Jan 8;56(2):836-41. doi: 10.1167/iovs.14-13864.
5
Evaluation of Meibomian Gland Dysfunction and Local Distribution of Meibomian Gland Atrophy by Non-contact Infrared Meibography.非接触式红外睑板腺造影评估睑板腺功能障碍及睑板腺萎缩的局部分布
Curr Eye Res. 2015;40(10):982-9. doi: 10.3109/02713683.2014.971929. Epub 2014 Oct 20.
6
Peripheral neuropathy and tear film dysfunction in type 1 diabetes mellitus.1型糖尿病中的周围神经病变和泪膜功能障碍。
J Diabetes Res. 2014;2014:848659. doi: 10.1155/2014/848659. Epub 2014 Aug 7.
7
Meibomian gland dropout in patients with dry eye disease in China.中国干眼症患者的睑板腺缺失情况。
Curr Eye Res. 2014 Oct;39(10):965-72. doi: 10.3109/02713683.2014.891748. Epub 2014 Jul 22.
8
[Meibomian gland morphology study progression].[睑板腺形态学研究进展]
Zhonghua Yan Ke Za Zhi. 2014 Apr;50(4):299-302.
9
Tear film osmolarity in patients with diabetes mellitus.糖尿病患者的泪膜渗透压。
Ophthalmic Res. 2013;50(1):1-5. doi: 10.1159/000345770. Epub 2013 Feb 22.
10
Assessment of tear film stability in dry eye with a newly developed keratograph.应用新型角膜地形图仪评估干眼的泪膜稳定性。
Cornea. 2013 May;32(5):716-21. doi: 10.1097/ICO.0b013e3182714425.